Literature DB >> 23727017

MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2.

Ayumu Sugiura1, Shun Nagashima, Takeshi Tokuyama, Taku Amo, Yohei Matsuki, Satoshi Ishido, Yoshihisa Kudo, Heidi M McBride, Toshifumi Fukuda, Nobuko Matsushita, Ryoko Inatome, Shigeru Yanagi.   

Abstract

The mitochondrial ubiquitin ligase MITOL regulates mitochondrial dynamics. We report here that MITOL regulates mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) domain formation through mitofusin2 (Mfn2). MITOL interacts with and ubiquitinates mitochondrial Mfn2, but not ER-associated Mfn2. Mutation analysis identified a specific interaction between MITOL C-terminal domain and Mfn2 HR1 domain. MITOL mediated lysine-63-linked polyubiquitin chain addition to Mfn2, but not its proteasomal degradation. MITOL knockdown inhibited Mfn2 complex formation and caused Mfn2 mislocalization and MAM dysfunction. Sucrose-density gradient centrifugation and blue native PAGE retardation assay demonstrated that MITOL is required for GTP-dependent Mfn2 oligomerization. MITOL knockdown reduced Mfn2 GTP binding, resulting in reduced GTP hydrolysis. We identified K192 in the GTPase domain of Mfn2 as a major ubiquitination site for MITOL. A K192R mutation blocked oligomerization even in the presence of GTP. Taken together, these results suggested that MITOL regulates ER tethering to mitochondria by activating Mfn2 via K192 ubiquitination.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23727017     DOI: 10.1016/j.molcel.2013.04.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  114 in total

1.  DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1.

Authors:  Yi Liu; Xiaopin Ma; Hisashi Fujioka; Jun Liu; Shengdi Chen; Xiongwei Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-25       Impact factor: 11.205

Review 2.  Dynamin-related protein-1 as potential therapeutic target in various diseases.

Authors:  Surinder Singh; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

Review 3.  Mitochondrial protein quality control in health and disease.

Authors:  Michael J Baker; Catherine S Palmer; Diana Stojanovski
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 4.  Role of membrane contact sites in protein import into mitochondria.

Authors:  Susanne E Horvath; Heike Rampelt; Silke Oeljeklaus; Bettina Warscheid; Martin van der Laan; Nikolaus Pfanner
Journal:  Protein Sci       Date:  2015-02-12       Impact factor: 6.725

5.  Mitochondrial outer-membrane E3 ligase MUL1 ubiquitinates ULK1 and regulates selenite-induced mitophagy.

Authors:  Jie Li; Wei Qi; Guo Chen; Du Feng; Jinhua Liu; Biao Ma; Changqian Zhou; Chenglong Mu; Weilin Zhang; Quan Chen; Yushan Zhu
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 6.  Mitochondrial dynamics and their potential as a therapeutic target.

Authors:  B N Whitley; E A Engelhart; S Hoppins
Journal:  Mitochondrion       Date:  2019-06-19       Impact factor: 4.160

Review 7.  Mitochondrial network remodeling: an important feature of myogenesis and skeletal muscle regeneration.

Authors:  Fasih Ahmad Rahman; Joe Quadrilatero
Journal:  Cell Mol Life Sci       Date:  2021-03-22       Impact factor: 9.261

Review 8.  Mitophagy in tumorigenesis and metastasis.

Authors:  Logan P Poole; Kay F Macleod
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

Review 9.  Protecting the mitochondrial powerhouse.

Authors:  Morten Scheibye-Knudsen; Evandro F Fang; Deborah L Croteau; David M Wilson; Vilhelm A Bohr
Journal:  Trends Cell Biol       Date:  2014-12-11       Impact factor: 20.808

Review 10.  Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Prospective Roles in Kidney Disease.

Authors:  Peng Gao; Wenxia Yang; Lin Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.